This article, originally published on XIFIN’s blog, explains why laboratories must embrace digital pathology technology and seamlessly integrate it into their LIS and associated artificial intelligence applications — or risk being left behind with a shrinking bottom-line. With the quickly evolving use of artificial intelligence tools, labs are increasingly seeing the benefits. For example, Proscia’s DermAI™ sorts and classifies cases to ensure that high-impact cases are always reviewed first.